GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Bone Marrow Transplantation

• Publication date

  2013-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bmt.2012.200PMID 23085826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

  2015cited by this paper
• Higher angiopoietin-2 and VEGF levels predict shorter EFS and increased non-relapse mortality after pediatric hematopoietic SCT

  2013cited by this paper
• Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.

  2012cited by this paper
• Dentin matrix protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation.

  2011cited by this paper
• Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system.

  2011cited by this paper
• Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation

  2011cited by this paper
• Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy

  2011cited by this paper
• The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation.

  2011cited by this paper
• Increased Dkk3 protein expression in platelets and megakaryocytes of patients with myeloproliferative neoplasms

  2010cited by this paper
• Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.

  2010cited by this paper
• Trends of hematopoietic stem cell transplantation in the third millennium

  2009cited by this paper
• Angiogenesis and vascular endothelial growth factor‐/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2‐V617F mutational status

  2009cited by this paper
• CD105 positive neovessels are prevalent in early stage carotid lesions, and correlate with the grade in more advanced carotid and coronary plaques

  2009cited by this paper
• The Effect of Graft-Versus-Host Disease on Skin Endothelial and Epithelial Cell Chimerism in Stem-Cell Transplant Recipients

  2009cited by this paper
• Vascular endothelium as 'novel' target of graft-versus-host disease.

  2008cited by this paper
• Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy

  2008cited by this paper
• Donor-derived cells and human graft-versus-host disease of the skin.

  2007cited by this paper
• Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.

  2007cited by this paper
• VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation.

  2007cited by this paper
• Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation.

  2007cited by this paper
• Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation

  2006cited by this paper
• Role of angiogenesis in chronic lymphocytic leukemia

  2006cited by this paper
• Angiogenesis: the VE-cadherin switch.

  2006cited by this paper
• Angiogenesis in nodal B cell lymphomas: a high throughput study

  2006cited by this paper
• Acute graft-versus-host disease: from the bench to the bedside.

  2005cited by this paper
• National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

  2005cited by this paper
• Cytokine profiles in stem cell transplantation: Possible use as a predictor of graft-versus-host disease

  2005cited by this paper
• Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells.

  2005cited by this paper
• Over‐expression of tumor necrosis factor‐alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis

  2005cited by this paper
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

  2005cited by this paper
• Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Bone marrow angiogenesis and circulating plasma cells in multiple myeloma

  2003cited by this paper
• Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.

  2003cited by this paper
• Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer

  2002cited by this paper
• Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia

  2002cited by this paper
• A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability.

  2002cited by this paper
• Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.

  2002cited by this paper
• Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease.

  2002cited by this paper
• Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)

  2001cited by this paper
• Endoglin: An accessory component of the TGF‐β‐binding receptor‐complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies

  2001cited by this paper
• Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.

  2000cited by this paper
• Peripheral Blood Platelets Express VEGF-C and VEGF which Are Released during Platelet Activation

  1998cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Review Article Vascular Endothelial Growth Factor-related Pathways in Hemato-lymphoid Malignancies

  year unknowncited by this paper

• Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients

  2023cites this paper
• Circulating endothelial cells and endothelial progenitor cells as potential predictors of acute GVHD after allogeneic hematopoietic stem cell transplantation

  2022cites this paper
• Early Endothelial Activation in a Mouse Model of Graft vs Host Disease Following Chemotherapy

  2021cites this paper
• Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort

  2021cites this paper
• Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease

  2021cites this paper
• Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation

  2021cites this paper
• Spatio-Temporal Bone Remodeling after Hematopoietic Stem Cell Transplantation

  2020cites this paper
• Peripheral blood schistocytes in the acute phase after allogeneic or autologous stem cell transplantation assessed by digital microscopy

  2019cites this paper
• Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide

  2019cites this paper
• The Endothelium During Allogeneic Stem Cell Transplantation

  2019cites this paper
• Manifestations of Chronic GVHD in Other Organ Systems

  2019cites this paper
• Application of “Primed” Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation: Current Status and Future Prospects

  2019cites this paper
• High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease

  2018cites this paper
• Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ

  2018cites this paper
• Repository of the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association

  2018cites this paper
• Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation

  2017cites this paper
• Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells

  2017cites this paper
• Initiation of acute graft-versus-host disease by angiogenesis.

  2016cites this paper
• Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.

  2016cites this paper
• Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease.

  2016cites this paper
• Raiders of the lost mark – endothelial cells and their role in transplantation for hematologic malignancies

  2016cites this paper
• Prognostic significance of vascular endothelial growth factor and circulating endothelial cells for early and late outcomes of allogeneic hematopoietic stem cell transplantation

  2015cites this paper
• Numerical impairment of nestin+ bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML

  2015cites this paper
• Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

  2015cites this paper
• Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD.

  2014cites this paper